- Home
- SCLX vs CBNA Comparison
SCLX vs CBNA Comparison
Compare SCLX & CBNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- CBNA
- Stock Information
- Founded
- SCLX 2011
- CBNA 2006
- Country
- SCLX United States
- CBNA United States
- Employees
- SCLX N/A
- CBNA N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- CBNA
- Sector
- SCLX Health Care
- CBNA
- Exchange
- SCLX Nasdaq
- CBNA NYSE
- Market Cap
- SCLX 130.1M
- CBNA 133.2M
- IPO Year
- SCLX N/A
- CBNA 2024
- Fundamental
- Price
- SCLX $0.61
- CBNA $24.01
- Analyst Decision
- SCLX Strong Buy
- CBNA Strong Buy
- Analyst Count
- SCLX 3
- CBNA 2
- Target Price
- SCLX $11.33
- CBNA $28.50
- AVG Volume (30 Days)
- SCLX 184.3K
- CBNA 44.9K
- Earning Date
- SCLX 11-26-2024
- CBNA 10-29-2024
- Dividend Yield
- SCLX N/A
- CBNA N/A
- EPS Growth
- SCLX N/A
- CBNA N/A
- EPS
- SCLX N/A
- CBNA 4.49
- Revenue
- SCLX $50,833,000.00
- CBNA $49,968,000.00
- Revenue This Year
- SCLX $32.77
- CBNA N/A
- Revenue Next Year
- SCLX $50.71
- CBNA N/A
- P/E Ratio
- SCLX N/A
- CBNA $5.34
- Revenue Growth
- SCLX 9.41
- CBNA 76.01
- 52 Week Low
- SCLX $0.54
- CBNA $20.10
- 52 Week High
- SCLX $2.63
- CBNA $25.00
- Technical
- Relative Strength Index (RSI)
- SCLX 28.71
- CBNA N/A
- Support Level
- SCLX $0.73
- CBNA N/A
- Resistance Level
- SCLX $1.14
- CBNA N/A
- Average True Range (ATR)
- SCLX 0.11
- CBNA 0.00
- MACD
- SCLX -0.04
- CBNA 0.00
- Stochastic Oscillator
- SCLX 11.99
- CBNA 0.00
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About CBNA CHAIN BRIDGE BANCORP INC
Chain Bridge Bancorp Inc is engaged in banking industry. It offers commercial and personal banking services, including deposits, treasury management, payments, loans, commercial lending, residential mortgage financing, consumer loans, trusts and estate administration, wealth management, and asset custody.